Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Reducing AKI Risk in Acute Type A Aortic Dissection
NCT06622291Phase 4Completed
- Sponsor
- Beijing An Zhen Hospital
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of nitric oxide in acute kidney injury (AKI), sponsored by Beijing An Zhen Hospital. Started Nov 2024; status: completed.
02
Drugs
nitric oxide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06622291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06622291.